Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr α-synuclein mutation

Annals of Neurology

Volumn 49, Issue 3, 2001, Pages 313-319

  Spira, Paul J ^a   Sharpe, David M ^b   Halliday, Glenda ^c   Cavanagh, Julie ^d   Nicholson, Garth A ^a,d  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b Department of Microbiology and Infectious Diseases   (Australia)

^c NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; ANTIPARKINSON AGENT; BENSERAZIDE; BENZATROPINE; BROMOCRIPTINE; CARBIDOPA; CARBIDOPA PLUS LEVODOPA; DEXAMPHETAMINE; DNA; LEVODOPA; METHYSERGIDE; SELEGILINE; VALPROIC ACID;

ADULT; ARTICLE; BRADYKINESIA; CLINICAL ARTICLE; COGNITIVE DEFECT; GAIT DISORDER; GENE MUTATION; HUMAN; MALE; MYOCLONUS; NEUROLOGIC DISEASE; PARKINSONISM; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREMOR;

ADULT; AGE OF ONSET; ALPHA-SYNUCLEIN; BRAIN; GREECE; HUMANS; MALE; MIDDLE AGED; MUTATION; NERVE TISSUE PROTEINS; PARKINSONIAN DISORDERS; SYNUCLEINS;

EID: 0035097503     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.67     Document Type: Article

References (42)

1. Mutarion in the alpha-synuclein gene identified in families wirh Parkinson's disease
2. Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations: The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD)
3. Generic epidemiology of Parkinson's disease
4. Mapping of a gone for Parkinson's disease to chromosome 4q21-q23
5. Generics of Parkinson's disease
6. The genetics of Parkinson's disease and parkinsonian syndromes
7. Clinical genetic analysis of Parkinson's disease in the Contursi kindred
8. A large kindred with autosomal dominant Parkinson's disease
9. Diagnostic criteria for Parkinson's disease
10. Mutated alpha-synuclein gene in two Greek kindreds with familial PD: Incomplete penetrance?
11. Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding α-synuclein
12. Alphasvnuclein mutation associated with familial Parkinson's disease in two new Greek kindred
13. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
14. Autosomal dominant Patkinson's disease and alpha-synuclein
15. Low frequency of alpha-synculein mutations in familial Parkinson's disease
16. Filamentous nerve cell inclusions in neurodegenerative diseases: Tauopathies and alpha-synucleinopathies
17. Alpha-synuclein in Lewy body disease and Alzheimer's disease
18. Tau and synuclein and their role in neuropathology
19. Alpha synuclein in neurodegenerative disorders: Murderer or accomplice?
20. Alpha-synuclein and Parkinson's disease
21. Molecular pathogenesis of movement disorders: Are protein aggregates a common link in neuronal degeneration?
22. Synucleins: Keys to the mechanisms of neurodegenerative diseases?
23. Dopaminergic loss and inclusion body formation in α-synuclein mice: Implications for neurodegenerative disorders
24. Variability and validity of polymorphism association studies in Parkinson's disease
25. Familial parkinsonism with depression: A clinicopathological study
26. Dominantly inherited apathy, central hypoventilation, and Parkinson's syndrome: Clinical, biochemical, and neuropathologic studies of two new cases
27. Hereditary mental depression and parkinsonism with taurine deficiency
28. Familial fatal parkinsonism with alveolar hypoventilation and mental depression
29. Familial parkinsonism, apathy, weight loss, and central hypoventilation: Successful long-term management
30. Familial parkinsonism and dementia with ballooned neurons, argyrophilic neuronal inclusions, atypical neurofibrillary tangles, tau-negative astrocytic fibrillary tangles, and Lewy bodies
31. Clinical features of familial diffuse Lewy body disease
32. Familial parkinsonism, dementia, and Lewy body disease: Study of family G
33. Hereditary form of parkinsonism-dementia
34. What clinical features are most useful no distinguish definite multiple system atrophy from Parkinson's disease?
35. Time course of symptomatic orthostatic hyporension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: A clinicopathological study
36. Myoclonus
37. Cortical myoclonus in levodopa-responsive parkinsonism
38. Levodopa-induced myoclonus
39. Elecrrophysiological observations in hereditary, parkinsonismdementia with Lewy body pathology
40. Dementia with Lewy bodies
41. Distinctive neuropathology revealed by alpha-synuclein antibodies in heredirary parkinsonism and dememtia linked to chromosome 4p
42. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation